MENEGATTI, Enea
 Distribuzione geografica
Continente #
NA - Nord America 9.815
AS - Asia 5.677
EU - Europa 4.783
SA - Sud America 947
AF - Africa 105
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 4
Totale 21.342
Nazione #
US - Stati Uniti d'America 9.652
SG - Singapore 2.140
FI - Finlandia 2.055
CN - Cina 1.481
BR - Brasile 742
UA - Ucraina 673
VN - Vietnam 589
IT - Italia 475
HK - Hong Kong 474
DE - Germania 446
GB - Regno Unito 336
TR - Turchia 332
FR - Francia 223
SE - Svezia 188
JP - Giappone 154
IN - India 150
RU - Federazione Russa 134
MX - Messico 77
AR - Argentina 70
BD - Bangladesh 69
CA - Canada 61
IQ - Iraq 51
PL - Polonia 48
ZA - Sudafrica 42
CO - Colombia 40
AT - Austria 33
NL - Olanda 33
ID - Indonesia 32
PK - Pakistan 31
EC - Ecuador 29
ES - Italia 22
LT - Lituania 20
BE - Belgio 18
PH - Filippine 18
RO - Romania 18
CL - Cile 16
JO - Giordania 15
SA - Arabia Saudita 15
UZ - Uzbekistan 15
VE - Venezuela 15
MY - Malesia 14
TH - Thailandia 14
KR - Corea 13
MA - Marocco 13
IL - Israele 12
PY - Paraguay 11
CZ - Repubblica Ceca 10
NP - Nepal 10
PE - Perù 10
CH - Svizzera 9
GR - Grecia 8
IR - Iran 8
UY - Uruguay 8
AE - Emirati Arabi Uniti 7
DZ - Algeria 7
EG - Egitto 7
AU - Australia 6
AZ - Azerbaigian 6
BF - Burkina Faso 6
BO - Bolivia 6
ET - Etiopia 6
PT - Portogallo 6
AL - Albania 5
HU - Ungheria 5
KE - Kenya 5
KZ - Kazakistan 5
NZ - Nuova Zelanda 5
PA - Panama 5
DO - Repubblica Dominicana 4
KW - Kuwait 4
TN - Tunisia 4
TW - Taiwan 4
BH - Bahrain 3
CR - Costa Rica 3
GT - Guatemala 3
JM - Giamaica 3
MD - Moldavia 3
NG - Nigeria 3
OM - Oman 3
AM - Armenia 2
AO - Angola 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
GA - Gabon 2
HN - Honduras 2
LV - Lettonia 2
MK - Macedonia 2
RS - Serbia 2
SN - Senegal 2
XK - ???statistics.table.value.countryCode.XK??? 2
YE - Yemen 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BG - Bulgaria 1
BW - Botswana 1
BZ - Belize 1
DK - Danimarca 1
EU - Europa 1
GD - Grenada 1
HR - Croazia 1
IE - Irlanda 1
Totale 21.329
Città #
Helsinki 1.905
Singapore 1.310
Woodbridge 979
Ashburn 948
Fairfield 782
Houston 725
Jacksonville 721
Chandler 565
Santa Clara 540
Hong Kong 454
Ann Arbor 448
San Jose 442
Beijing 406
Seattle 299
Wilmington 284
Cambridge 252
Ho Chi Minh City 214
Izmir 205
Nanjing 203
Tokyo 147
Hanoi 141
Princeton 141
New York 136
Los Angeles 128
Boardman 113
Lauterbourg 111
Dallas 109
San Diego 84
São Paulo 77
Munich 69
Shenyang 63
Milan 59
Mexico City 57
Nanchang 55
Shanghai 52
Hefei 49
Hebei 39
Tianjin 38
Changsha 37
Warsaw 37
Brooklyn 33
Jiaxing 33
Dearborn 32
Rio de Janeiro 32
Chicago 31
Jinan 29
Baghdad 28
Buffalo 28
Falkenstein 28
Ferrara 28
London 28
Montreal 26
Norwalk 26
Chennai 25
Frankfurt am Main 25
Orem 25
San Mateo 25
Denver 24
Johannesburg 24
Stockholm 24
Belo Horizonte 23
Mountain View 23
Vienna 23
Rome 22
Da Nang 21
Moscow 21
Poplar 21
Atlanta 20
Manchester 20
Redwood City 20
Falls Church 19
Kunming 19
Ningbo 19
Guangzhou 18
Haiphong 18
Brussels 17
Turku 17
Auburn Hills 16
Bengaluru 16
Mumbai 16
Ankara 15
Brasília 15
San Francisco 14
Tashkent 14
Amman 13
Medellín 13
Biên Hòa 12
Philadelphia 12
Verona 12
Zhengzhou 12
Amsterdam 11
Bangkok 11
Boston 11
Curitiba 11
Hangzhou 11
Indiana 11
Orange 11
Bogotá 10
Dhaka 10
Guayaquil 10
Totale 14.606
Nome #
Microemulsions of retinoids and pharmaceutical compositions containing them 1.968
Studio di uno spray topico di sucralfato gel e cidofovir per la terapia antivirale di ovini 369
Skin care: The innovative nanotechnology to improve the performance of delivery systems 242
Cationic liposomes as potential carriers for ocular administration of peptides with anti-herpetic activity 239
Amphiphilic association systems for amphotericin B delivery 225
Bioadhesive sucralfate gel-based suspension containing cidofovir for spray treatment of viral infections in lamb and sheep 218
Biodegradable microparticles for sustained delivery of tetracycline to the periodontal pocket: Formulatory and drug release studies 217
Clotrimazole Nanoparticle gel for mucosal administration. 216
Respiratory Drug Delivery 215
Cellulose acetate butyrate-pH/thermosensitive polymer microcapsules containing aminated poly(vinyl alcohol) microspheres for oral administration of DNA 215
Cubosome dispersions as delivery systems for percutaneous administration of indomethacin 214
Amphiphilic association systems for Amphotericin B delivery 210
A novel multicompartimental system based on aminated poly(vinyl alcohol) microspheres/succinoylated pullulan microspheres for oral delivery of anionic drugs 208
Ursodeoxycholic acid for oral administration: a formulatory study of a suspension. 207
Brain Targeting of an Antiischemic Agent by Nasal Administration of Microparticles 202
Budesonide microparticles for the treatment of Crohn's disease 199
Non-phospholipid vesicles as carriers for peptides and proteins: production, characterization and stability studies 198
Formulation study for the antitumor drug camptothecin: liposomes, micellar solutions and a microemulsion 198
Characterization of low -molecular-mass trypsin isoinhibitors from oil-rape (Brassica napus var. oleifera) seed 195
Nanoparticulate lipid dispersions for bromocriptine delivery: characterization and in vivo study 195
Design and characterization of fenretinide containing organogels 195
Cationic lipid nanosystems as carriers for nucleic acids 194
Cationic liposomes as carriers for ocular administration of anti herpetic peptides 193
Characterisation of potential adenosine A1 receptor prodrugs of adenosine derivatives with antiischemic properties 192
Active substance controlled release device for sanitization of spaces susceptible of containing degenerative organic material 189
Effects of phospholipid based formulations on in vitro and in vivo percutaneous absorption of methyl nicotinate 185
Influence of formulation and process parameters on pellet production by powder layering technique 184
Microparticles as delivery systems for local delivery to the oral cavity. 183
Intranasal immunization in mice with non-ionic surfactants vesicles containing HSV immunogens: a preliminary study as possible vaccine against genital herpes 182
Kinetics of bromocriptine release from microspheres: Comparative analysis between different in vitro models 180
Cellulose acetate butyrate microcapsules containing dextran ion-exchange resins as self-propelled drug release system 180
Nanostructured lipid carriers as delivery systems for parkinson’s therapy 178
Eudragit® microparticles for the release of budesonide: A comparative study 177
Ethosomes and liposomes as topical vehicles for azelaic acid: A preformulation study 175
Preparation of liposomes by reverse-phase evaporation using alternative organic solvents 175
Characterization of five new low-molecular-mass trypsin inhibitors from white mustard (Sinapis alba L.)seed 174
Nanosystems for skin hydration: a comparative study 174
Effect of cationic liposome composition on in vitro cytotoxicity and protective effect on carried DNA 174
Bioencapsulation methods for cell inclusion in polysaccharidic matrices for clinical applications 174
Liposome-associated retinoids: production, characterization and antiproliferative activity on neoplastic cells 173
Alginate and cell combination product for wound healing 172
Cationic liposomes carrying anti herpetic peptides as potential ocular vaccine 171
In vitro cytotoxic activity of some glucosinolate-derived products generated by myrosinase hydrolysis 170
Cationic nanostructured lipid carrier (NLC) and monoolein aqueous dispersions (MAD) as potential carriers for nucleic acids 169
Lipid-based supramolecular systems for topical application: A preformulatory study 169
Preparation and characterisation of thermoresponsive poly [(N-isopropylacrylamide-co-acrylamide-co(hydroxyethyl acrylate)] microspheres as a matrix for the pulsed release of drugs 167
Effect of charge and lipid concentration on in-vivo percutaneous absorption of methyl nicotinate from liposomal vesicles 166
Properties and applications of liposomes in cosmetics 162
Influence of liposomal formulation parameters on the in vitro absorption of methyl nicotinate 162
Eudragit® /Pluronic nanoparticles as mucosal delivery system for peptides and proteins: an in vitro study 162
Combination of alginate and cells for skin regeneration 162
Selective inhibition of human mast cell tryptase by gabexate mesylate, an antiproteinase drug 159
Poly[(N-isopropylacrylamide-co-acrylamide-co-(hydroxyethylmethacrylate)]thermoresponsive microspheres: an accurate method based on solute exclusion technique to determine the volume phase transition temperature 157
Cross-enzyme inhibition by gabexate mesylate: Formulation and reactivity study 156
In vitro antiproliferative activity of isothiocyanates and nitriles generated by myrosinase-mediated hydrolysis of glucosinolates from seeds of cruciferous vegetables 156
Colloidal dispersions for the delivery of acyclovir: A comparative study 155
GELATIN MICROSPHERES AS A NEW APPROACH FOR THE CONTROLLED DELIVERY OF SYNTHETIC OLIGONUCLEOTIDES AND PCR-GENERATED DNA FRAGMENTS 155
Spray dried Eudragit microparticles as encapsulation devices for vitamin C 154
Production and characterization of biodegradable microparticles for the controlled delivery of proteinase inhibitors 154
Preparation and characterisation of poly(vinyl alcohol)/cyclodextrin microspheres as matrix for inclusion and separation of drugs 154
Hyaluronan-based microspheres as tools for drug delivery: a comparative study 153
Dextran cross-linked gelatin microspheres as a drug delivery system 152
Liposomes- and ethosomes-associated distamycins: a comparative study 151
Nasal administration and brain targeting of an antiischemic agent 150
Preparation and characterization of cationic microspheres for gene delivery 150
Development of polymethacrylic/poloxamer microparticles for topical administration of biotech drugs 149
Preparation and characterization of collagen sponges for dermo-cosmetic applications 148
Materie Prime: Eccipienti 145
Myrosinase-generated isothiocyanate from glucosinolates: Isolation, characterization and in vitro antiproliferative studies 143
Eudragit microparticles as a possible tool for ophthalmic administration of acyclovir 142
Ethosomes for the delivery of anti-HSV-1 molecules: preparation, characterization and in vitro activity. 141
Lecithin organogels as cosmetic formulations for methyl nicotinate 141
Production of pellet by powder layering technique: coating with acrylic polymers for enteric drug release 140
Peptide-based cationic liposomes and micelles as a new tool for nonviral gene delivery 139
N6-cyclopentyladenosine : selective brain targeting by nasal administration of microparticles 136
Production and characterization of cubosome: a new tool for percutaneous administration of lipophilic drugs 135
Solid Lipid Nanoparticles as Delivery Systems for Bromocriptine 135
Innovative nanotechnology based systems for dermal application 134
Preparation and characterization of starch/cyclodextrin bioadhesive microspheres as platform for nasal administration of Gabexate Mesylate (Foy (R)) in allergic rhinitis treatment 134
Eudragit®/Pluronic nanoparticles for the administration of peptides and proteins 134
Brain Uptake of an Antiischemic Agent by Nasal Administration of Microparticles 133
DNA binding activity and inhibition of DNA-protein interactions. Differential effects of tetra-p-amidino-phenoxyneopentane and its 2′-bromo derivative 129
Ethosomes for the delivery of anti-herpetic molecules 127
Lipid-based dispersions for drug delivery 126
Diclofenamic acid-vitamin C conjugates: stability and interaction studies with ascorbate transporters 125
Eudragit/Pluronic microparticles for topical administration of peptides and proteins 123
NEW DELIVERY SYSTEMS FOR RETINOIDS APPLICATION 119
Peptide-based molecules for the production of positive charged liposomes and micelles 118
Therapeutic paint for simultaneous delivery of sucralfate gel and cidofovir in the treatment of veterinary viral skin infections 118
Spray-drying production of trypsin-containing microparticles 118
Niosomes for vaginal administration of an antiherpetic peptide 116
Spray drying production of trypsin containing microparticles 115
Liposomes and micellar solutions for the delivery of some benzoheterocyclic derivatives of distamycin A 114
In vitro comparison of four anti-inflammatory topical medications 114
Modulation of protease activity by NO-mediated S-nitrosylation. 114
Soft agglomerates containing microencapsulated levothyroxine for buccal or oral delivery 114
null 113
Oligonucleotide-carrying microspheres. Production, characterization and release characteristics 113
Production and antiproliferative activity of liposomes containing the antitumour drug chromomycin A(3) 113
Semisolid formulations based on MAD or NLC for mucosal administration of Clotrimazole 113
Totale 18.240
Categoria #
all - tutte 82.876
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 4.209
Totale 87.085


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021462 0 0 0 0 0 0 0 0 0 163 217 82
2021/20221.252 43 153 114 79 41 52 64 77 36 95 125 373
2022/20231.302 151 48 32 164 221 224 25 130 170 8 88 41
2023/2024623 76 83 24 10 43 114 29 40 8 30 36 130
2024/20252.656 74 41 183 68 385 282 88 152 465 264 391 263
2025/20268.549 698 375 662 1.113 891 471 716 423 2.506 694 0 0
Totale 21.430